Preparing a Sequence Listing for the USPTO is a formal process governed by 37 CFR 1.821–1.825 and requires strict adherence to format, content, and electronic submission rules. The goal is to present nucleotide and amino acid sequence data in a standardized, computer-readable way that supports examination and database use.​ Regulatory basis